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Impaired explicit self-awareness but preserved behavioral regulation in patients with 
Alzheimer Disease 
Objectives: Impairments of metacognitive skills represent a critical symptom in Alzheimer 
Disease (AD) because it frequently results in a lack of self-awareness. However, recent findings 
suggest that, despite an inability to explicitly estimate their own cognitive functioning, patients 
might demonstrate some implicit recognition of difficulties. In this study, we tested whether a 
behavioral dissociation between explicit and implicit measures of metacognition can be found 
in both healthy older controls (n = 20) and AD patients (n = 20). 
Methods: Our two groups of participants (AD vs. Controls) were asked to complete a forced-
choice perceptual identification test and to explicitly rate their confidence in each decision (i.e., 
explicit measure of metacognition). Moreover, they also had the opportunity to ask for a cue to 
help them decide if their response was correct (i.e., implicit measure of metacognition). 
Results: Data revealed that all participants asked for a cue more often after an incorrect 
response than after a correct response in the forced-choice identification test, indicating a good 
ability to implicitly introspect on the results of their cognitive operations. On the contrary, only 
healthy participants displayed metacognitive sensitivity when making explicit confidence 
judgments. 
Conclusion: Our findings suggest that implicit metacognition may be less affected than explicit 
metacognition in Alzheimer’s disease. 
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Introduction 
Humans have the ability to estimate the success of their cognitive processes, a capacity that is 
known as metacognition (Flavell, 1979). Impairments of metacognitive skills represent a 
critical neuropsychiatric symptom in various clinical diagnoses such as Alzheimer’s Disease 
(AD), frontotemporal dementia, autism, schizophrenia, or drug addiction (see Cosentino, 2014; 
Goldstein et al., 2009). Notably, one prominent symptom is anosognosia, or lack of self-
awareness. Lack of self-awareness for behavioral or cognitive impairment is problematic for 
patients because it has been linked to reduced engagement in remediation strategies (Clare, 
Wilson, Carter, Roth, & Hodges, 2004), poor adherence to medication (Patel & Prince, 2001), 
impaired management of functional difficulties (Koltai, Welsh-Bohmer, & Schmechel, 2001) 
as well as to an increase of the frequency of risky behaviors (Starkstein, Jorge, Mizrahi, Adrian, 
& Robinson, 2007). Moreover, it also contributes to caregivers’ burden (Seltzer, Vasterling, 
Yoder, & Thompson, 1997). 
Anosognosia is particularly frequent among AD patients. According to Orfei et al. (2010), for 
example, 42% of patients with mild AD could already be diagnosed as presenting a self-
awareness impairment, a figure that has been shown to increase over the course of the disease 
(e.g., Edmonds et al., 2018). Recently, numerous studies have thus been conducted in order to 
better understand which specific metacognitive deficits could account for the emergence of 
anosognosia in AD (e.g., Chapman et al., 2018; Thomas, Lee, & Balota, 2013). These studies 
have revealed that a specific impairment of metacognitive monitoring – i.e., a process by which 
individuals evaluate online their own functioning while performing a cognitive task – could be 
one of the mechanisms leading to anosognosia (Agnew & Morris, 1998; Chapman et al., 2018; 
Cosentino et al., 2016). As evidence for this, Consentino et al. (2016) have found that AD 
patients with impaired self-awareness were unable to make accurate confidence ratings when 
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completing a memory task, suggesting that these patients are not able to accurately evaluate 
their own memory performance.  
However, despite explicit overestimation of functioning, some authors have shown that AD 
patients could demonstrate emotional reactivity to cognitive failure in the same extent as 
healthy participants, revealing some implicit recognition of difficulties. Mograbi, Brown, Salas, 
and Morris (2012), for instance, have conducted an experiment in which AD patients had to 
complete two parallel tasks: one in a success condition and one in a failure condition. Explicit 
metacognition was assessed by asking participants to verbally report their performance for the 
task (i.e. global retrospective confidence judgments). Implicit metacognition was assessed 
using emotional reactivity (i.e., facial expression) of the participants while performing the task. 
The results indicated that, relative to matched controls, AD patients exhibited impaired explicit 
metacognition (i.e., their explicit metacognitive judgments were not calibrated with their actual 
performance). However, they showed comparable emotional reactivity to failure relative to 
success in performing tasks. Importantly, some recent data have suggested that such implicit 
emotional responses to experiences of failure in cognitive tasks could result in better long-term 
behavioral adaptation of unaware patients (Bomilcar, Morris, Brown, & Mograbi, 2018). Such 
findings are interesting because they are consistent with several theoretical frameworks which 
incorporate an implicit component in their model of self-awareness (e.g., the Cognitive 
Awareness Model – CAM, Agnew & Morris, 1998; the Comprehensive Dynamic Interactional 
Model, Toglia & Kirk, 2000). In these models, an implicit component is usually supposed to 
bypass explicit awareness, allowing the emergence of behavioral and affective regulation even 
when explicit awareness is impaired. These frameworks are also consistent with the Trace 
Accessibility model of metacognition proposed by Koriat (2007) which posits that 
metacognition is available in the form of implicit access to mental operations that can influence 
behavior even when it cannot be reported verbally. 
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Koriat’s Trace Accessibility model has recently been supported by various studies conducted 
in populations where explicit metacognition is not available or not fully mature as in young 
children (Balcomb & Gerken, 2008; Geurten & Bastin, 2018), infants (Goupil, Romand-
Monnier, & Kouider, 2016), or non-human animals (Vining & Marsh, 2015). For instance, 
Geurten and Bastin (2019) have created a procedure allowing to assess both explicit and implicit 
metacognition on the basis of paradigms originally developed for non-humans. They showed 
that this procedure can behaviorally capture young children’s metacognitive skills. Specifically, 
their data revealed that when participants were given the possibility to ask for a cue when they 
were uncertain about the correctness of their response during a perceptual identification test, 
2.5-year-old children had a lower rate of correct responses on items for which they required a 
cue than on items for which they did not require a cue, revealing an accurate implicit behavioral 
estimation of their performance. On the reverse, when children were explicitly asked to judge 
the certainty of their responses, they were unable to discriminate between their correct and 
incorrect identifications. 
Although data from studies conducted in children and non-humans seem to support a possible 
dissociation between an explicit and an implicit form of metacognition, such investigations are 
still needed in AD where data remain to be gathered to determine whether and when implicit 
metacognition is preserved. Moreover, to our knowledge, the small number of studies which 
have experimentally examined the potential dissociation between an explicit and an implicit 
metacognition have mostly relied on paradigm exploring whether AD patients were able to 
process the affective valence of failure (e.g., Bomilcar et al., 2018; Mograbi et al., 2012). These 
experiments were not designed to test whether patients were able to behaviorally react to a poor 
cognitive performance, as it is postulated by the CAM model (Morris & Hannesdottir, 2004) 
and the Trace Accessibility model (Koriat, 2007). 
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In this context, the primary goal of this study was (a) to test whether AD patients have some 
metacognitive skills that could be used implicitly to regulate their performance and (b) to 
confirm that these skills cannot be captured by traditional explicit measures of metacognition. 
To this end, a paradigm inspired by the one created by Geurten and Bastin (2019) for young 
children has been adapted and administered to a group of AD patients and their matched 
controls in order to assess both their explicit and their implicit metacognitive monitoring skills. 
Specifically, all the participants were asked to complete a forced-choice perceptual 
identification test and to rate their confidence in each decision (explicit metacognitive measure). 
Moreover, in addition to their confidence rating, participants also had the opportunity to ask for 
a cue to help them decide if their response was correct (implicit metacognitive measure). 
Participants exhibiting explicit metacognitive abilities should demonstrate higher confidence 
after a correct response than after an incorrect response. Similarly, participants with implicit 
metacognitive abilities should be more likely to ask for a cue after inaccurate than accurate 
responses. 
If our hypotheses are correct and that patients with AD are able to engage in accurate implicit 
metacognition, but show altered explicit metacognition as compared to matched controls, we 
would expect a lower accuracy for the explicit measure than for the implicit measure of 
metacognition. Furthermore, we would also anticipate that controls would outperform patients, 
but only for the explicit metacognitive index. On the reverse, if AD patients show an 
impairment for both the implicit and the explicit measure of metacognition, we would expect 
them to be outperformed by healthy participants for the two types of metacognitive measures. 
Finally, a third possible scenario could be that both AD patients and healthy participants are 
equally able to make accurate explicit and implicit metacognitive judgments. In this case, we 
would expect our two groups of participants to show a similar pattern of results for the two 
classes of metacognitive measures. However, given the amount of data indicating that explicit 
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metacognitive monitoring processes are frequently impaired in AD (e.g., Ansell & Bucks, 2006; 
Cosentino, Metcalfe, Butterfield, & Stern, 2007; Cosentino et al., 2016; Galeone, Pappalardo, 
Chieffi, Iavarone, & Carlomagno, 2011), this hypothesis appears quite unlikely, at least at the 
group level. 
Methods 
Participants 
Twenty patients (7 females) with mild to moderate clinically probable AD and their matched 
controls participated at this study. Patients were recruited via collaboration with the Memory 
Center of the Department of Neurology of CHU Liège (Belgium). The age of the AD patients 
ranged from 64 to 84 years and their education level ranged from 8 to 21 years. Patients were 
diagnosed as having major neurocognitive disorder according to the Diagnostic and Statistical 
Manual of mental disorders (DSM-V) and they met clinical criteria for probable Alzheimer’s 
Disease following the NIA-AA recommendations (McKhann et al., 2011). Their Mini Mental 
State Examination (MMSE) score was between 18 and 25 (Folstein, Folstein, & McHugh, 
1975). They were identified as having a relative deficit of self-awareness on the basis of an 
interview conducted by the neurologist who supervised their follow-up (ES) as well as on a 
significant discrepancy between self-reported and other-reported assessment of memory 
problems (i.e., a self and other-form of a questionnaire adapted from the Memory Awareness 
Rating Scale was used for this evaluation; Clare, Wilson, Carter, Roth, & Hodges, 2002) as 
compared to healthy controls. The patients had no mental retardation, no history of psychiatric 
or neurological illness. They were not engaged in substance abuse and were free of medication 
that could negatively affect cognitive functioning. 
Moreover, one healthy participant was matched with each AD patient for age, gender (n = 20; 
7 females), and education level. They were all non-institutionalized, alert, and subject to the 
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same exclusion criteria as the AD group. Their age ranged from 63 to 85 years and their 
education level ranged from 7 to 20 years. The control and the patient groups did not differ 
significantly in age or education, all ps > .54. No older adults were excluded as they all had 
MMSE scores above 27 (M = 29.35). Patients and controls characteristics are displayed in Table 
1. 
< Table 1 near here > 
The Sample size was determined a priori to reach a predicted power of .80 (α=.05, β=.20) for a 
double within-between interaction (small to medium effect size) with two groups and two 
repetitions, on the basis of a pilot study conducted on a sample of 12 patients with mild AD and 
their marched controls. 
Stimuli 
The stimuli consisted of 90 target-distractor pairs of two dimensional colored line drawings 
(objects and animals). During the test, target items were first presented in degraded form (40% 
blurring given using the cubist filter of the GNU Image Manipulation Program). To avoid 
differences in our two metacognitive measures being confounded with the fact that the 
identification task could be easier for healthy controls than for AD patients, we controlled 
participants’ identification performance by adjusting the level of difficulty of the target-
distractor pair of stimuli on a trial-by-trial basis. Specifically, the level of difficulty of the 
stimuli were adjusted using an adaptive staircase procedure (inpired by Fleming, Weil, Nagy, 
Dolan, & Rees, 2010), designed to result in convergence of 65% accuracy for individual 
performance (i.e., above-chance performance without reaching a ceiling). This specific rate of 
accuracy was chosen as opposed to the more classical 70% accuracy rate in order to slightly 
increase the sensitivity of the metacognitive tasks and, thus, avoid potential ceiling effects at 
the meta-level. Indeed, previous studies have shown that providing a metacognitive judgment 
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on an incorrect response was more difficult than providing a judgment on a correct response 
(e.g., Koriat, 2018). The level of difficulty of each pair were determined through a pretest in 
which 12 patients with mild AD and their matched controls were asked to complete four 
perceptual identification tests. During each test, participants were presented with 30 degraded 
pictures one at a time (1 s each) and then determined which of two drawings depicted the 
previously seen items. In all, 120 target-distractor pairs were randomly presented. Following 
the procedure described by Geurten and Bastin (2019), stimuli were then sorted into three 
categories depending on the average accuracy with which they were identified: (a) items that 
were correctly identified by more than two thirds of the participants in both groups (AD vs. 
controls) were classified as having a low level of difficulty (mean = 78.46%; SD = 5.2); (b) 
items that were identified correctly by more than one third, but less than two thirds, of the 
participants in each group were classified as having a medium level of difficulty (mean = 
51.1%; SD = 7.1); (c) items that were correctly identified by less than one third of the 
participants in each group were classified as having a high level of difficulty (mean = 19.6%; 
SD = 7.5). Thirty target-distractor pairs were selected in each category to be used as stimuli in 
the experiment. Moreover, a set of 90 additional colored line drawings selected to be either 
conceptually or perceptually related to one of each target-distractor pair (e.g., Moon – Star) 
served as cues during the implicit judgment phase. 
Procedure 
This study were conducted after the approval by ethics committees of the participating 
institution and with written informed consent of all participants. The procedure used was the 
same as the one created by Geurten and Bastin (2019). Each participant underwent a session 
lasting approximately 20 minutes during which a perceptual identification test was completed. 
For each item of this test, participants went through three successive phases: (a) an 
identification phase, (b) an explicit judgment phase (confidence scale), and (c) an implicit 
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judgment phase (cue selection). The latter two phases were counterbalanced so that half of 
participants in each group were presented with the explicit judgment phase first while the other 
half started with the implicit judgment phase (see Figure 1). 
The perceptual identification test was preceded by four practice trials so that participants could 
become familiar with the apparatus and the general procedure of the three phases of the test. 
They were given feedback on the basis of the correspondence between their identification 
response and their cue selection or their choice on the confidence scale (e.g., if participants 
selected the low-confidence option after an incorrect identification, they received positive 
feedback). Specifically, participants received feedback on the accuracy of their explicit 
judgments on odd trials and on the accuracy of their implicit judgments on even trials. At the 
end of the practice trials, every participant was able to correctly use both the explicit and the 
implicit scale of confidence. 
< Figure 1 near here > 
Identification phase 
A list of 33 degraded stimuli was displayed in random order for 1 second. After each item, 
participants were presented with a target-distractor pair of stimuli for an unlimited time and 
were asked to point to the drawing they had previously seen (forced choice). The experimenter 
then clicked on the selected picture to validate the response. The side of the screen in which the 
target stimulus was displayed was randomized over the trials. After each response, a blank 
screen appeared for 100 ms, followed by either the explicit or the implicit judgment phase. As 
previously mentioned, an adaptive staircase procedure (Fleming et al., 2010) was used to equate 
performance across participants. Specifically, three consecutive incorrect responses or two 
incorrect responses out of three trials resulted in a reduction of the level of difficulty by one 
step (i.e., a target-distractor pair from the lower category of difficulty was presented next), 
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whereas two or more correct responses out of three trials resulted in an increase of the difficulty 
level by one step (i.e., a target-distractor pair from the higher category of difficulty was 
presented next). 
Explicit judgment phase 
For each trial, both groups of participants rated their confidence in their responses using a 2-
point pictorial scale depicting low and high confidence in the form of two arrows pointing either 
up (to indicate high confidence) or down (to indicate low confidence). Participants were 
instructed to select the high-confidence point when they were “really sure” about the 
correctness of their answers and to select the low-confidence point when they were “not so 
sure” about the correctness of their answers. The experimenter clicked on the selected picture 
to record the answer. No feedback was provided. Low confidence was coded as 0 and high 
confidence was coded as 1. After each response, a blank screen was presented for 100 ms before 
moving to the next phase. 
Implicit judgment phase 
For each trial, participants had the opportunity to ask for a cue to help them to decide whether 
their response was correct. They were instructed to ask for a cue only when they felt they had 
made an error in identifying the target item. Specifically, a question (i.e., “Do you want a cue 
to help you to decide whether your response is correct?”) and two response buttons appeared 
in the center of the screen. Participants had to say aloud whether they wanted a cue. The 
experimenter pressed the “yes” button when a cue was requested and pressed the “no” button 
otherwise. Each choice was followed by a blank screen for 100 ms. No feedback was provided. 
Accepting the cue was coded 0 and declining the cue was coded 1. Depending on the 
experimental order, the cue appeared either directly after the blank screen or after the explicit 
judgment phase. In that way, participants’ explicit judgment was never affected by the 
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presentation of the cue. The cue, a picture either perceptually or conceptually related to the 
correct answer, appeared in the center of the screen for 3 seconds, followed by a blank screen 
for 100 ms. After completing these three phases, participants were once again presented with 
the target-distractor pairs and asked whether they would like to change their previous answer, 
then they moved on to the next trial. 
Results 
Differences were considered as significant when the p value was < .05. Preliminary analyses 
indicated no gender or phase order effects on any of the dependent variables, ts<1.56; ps>.12; 
further analyses were thus run on data collapsed across gender and phase order. 
Correct response rate 
First, to confirm that the identification performance were roughly equal between the AD 
patients and healthy older adults, we conducted a t test to compare the accuracy rate of these 
two groups. Performance accuracy appeared well regulated by the staircase procedure, as 
performance reached the predicted level and no significant differences were found between the 
AD (M = .67, SD = .10, range .59–.77) and the control group (M =.68, SD =.10, range .57–.78), 
t(38) =.36, p =.72, d =.14. 
Implicit vs. explicit judgment 
To show a dissociation between the explicit and implicit measures of metacognition, we directly 
compared the accuracy of participants’ confidence ratings with the accuracy of their cue 
selection. To do so, we calculated a measure of metacognitive sensitivity for both metacognitive 
measures: the A’ROC index (Galvin, Podd, Drga, & Whitmore, 2003). A’ROC is a non-
parametric and bias-free measure (i.e., theoretically uninfluenced by the overall propensity of 
a participant to give high or low judgments) from signal detection theory that plots the 
concordances (e.g., a high-confidence judgment on correct identification) against the 
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discordances (e.g., a high-confidence judgment on incorrect identification). An A’ROC of 0.5 
indicates no metacognitive discrimination between correct and incorrect responses. However, 
despite being bias-free, A’ROC could still be affected by variations in the performance at the 
cognitive level. One approach to deal with this problem is to use techniques to control for inter-
individual differences in performance through, for example, the implementation of a staircase 
procedure (see Fleming et al., 2014). 
We first examined whether both groups of participants were able to make above-chance explicit 
and implicit judgments. The results of the t tests showed that the metacognitive coefficients 
were significantly above chance in both groups for the implicit measure, ts>5.22, ps<.001, 
ds>1.2. However, if healthy older adults also showed above chance sensitivity for the explicit 
measure of metacognition, t(38) = 5.63, p<.001, d = 1.26, no significant differences against 0.5 
were found in the AD patients, t(38) = 0.64, p =.53, d = .15. 
To determine whether there were a significant difference between these two judgments when 
they were compared directly, we then conducted a 2 (Group: AD vs. Control) x 2 (Measure: 
explicit vs. implicit) mixed ANOVA on the A’ROC index. The results are presented in Figure 
2. They indicated that participants’ metacognitive accuracy was lower for the explicit measure 
(M = .56, SD = .13) than for the implicit measure (M = .62, SD = .10), F(1, 38) = 6.75, MSe = 
0.06, p = .01, η² = .07. This result is qualified by the significant group x measure interaction, 
F(1, 38) = 6.51, MSe = 0.06, p = .01, η² = .08. This interaction revealed that AD patients (M = 
.52; SD = 16) had lower metacognitive accuracy than older adults (M = .61; SD = .08) for the 
explicit measure of metacognition, F(1, 38) = 4.33, MSe = 0.07, p = .044, η² = .12, while this 
difference was not found for the implicit measure, F(1, 38) = 0.64, MSe = 0.01, p =.43, η² = .00 
(M = .62, SD = .10 vs. M = .61, SD = .09, for the AD group and the control group, respectively). 
No other effect was found, F = 0.97, p = .33. 
< Figure 2 near here > 
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Finally, in a more exploratory way, correlation analyses were conducted to determine whether 
explicit and implicit measures of metacognition were related to participants’ general cognitive 
functioning (i.e., MMSE scores). Results revealed a significant correlation with the explicit 
measure of metacognition in both AD patients, r = .54, p = .01, and control participants, r = 
.43, p = .04. However, no correlations were found with the implicit metacognitive measure, all 
rs<.10 ps>.20. 
Discussion 
The primary goal of the present experiment was to document the existence and preservation of 
some implicit metacognitive monitoring skills dissociated from explicit metacognitive 
processes in patients with mild to moderate AD who were clinically considered to present self-
awareness deficits. For this purpose, we adapted and used an experimental paradigm allowing 
participants to ask for a cue when they felt uncertain about their response and we compared this 
implicit measure of metacognition to a more classical explicit metacognitive measure. 
Moreover, in this study, we also took care to control for individual performance at the cognitive 
level in order to ensure that differences observed at the metacognitive level between our two 
groups were not due to changes in task performance (Fleming et al., 2010). 
Consistent with the hypothesis that AD patients have some preserved form of metacognitive 
skills, our results reveal that both AD patients and healthy controls asked for a cue more often 
after an incorrect response than after a correct response in the forced-choice identification test, 
as revealed by a metacognitive index of accuracy higher than chance in both groups. This 
pattern indicates a good ability of both healthy and AD participants to implicitly estimate their 
own cognitive performance. Regarding the explicit measure of metacognition, however, control 
participants – but not AD patients – displayed a metacognitive sensitivity that differs from 
chance when making explicit confidence judgments. Taken together, these findings suggest a 
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preservation of implicit metacognition in AD patients that is dissociated from their impaired 
explicit metacognition. 
From a theoretical perspective, these results are consistent with the CAM model which posits 
that an implicit retrieval mechanism allows participants to regulate their cognitive functioning 
at both a behavioral and an affective level (Morris & Hannesdottir, 2004). Importantly, the 
present study is among the first to provide direct evidence of an implicit behavioral regulation 
in AD patients. Indeed, previous experiments exploring the implicit component of the CAM 
model have mostly relied on procedure assessing AD patients’ affective responses to cognitive 
failures (e.g., Mograbi et al., 2012). To date, only clinical observation were available to support 
the hypothesis that AD patients may demonstrate some signs of behavioral reactions to 
cognitive errors, even when they are not able to explicitly report these errors (Mograbi & 
Morris, 2013). Furthermore, our findings also support the Trace Accessibility model (Koriat, 
2007) which proposes that some aspects of metacognitive operations are computed 
automatically, without explicit access to the results of this evaluation. Within this framework, 
our data are interesting because, if previous studies have found that implicit metacognition 
could emergence very early in the course of development (e.g., Balcomb & Gerken, 2008; 
Geurten & Bastin, 2018), our findings reveal that implicit metacognition could also be more 
resistant than explicit metacognition to cerebral degeneration effects, at least in the case of 
Alzheimer’s disease. 
These results, if there are confirmed, could have several major practical applications. Indeed, 
the data collected in this study provide critical information about the nature of possibly 
preserved metacognitive abilities in AD. This knowledge could be crucial for future research 
aiming at implementing revalidation programs based on patients preserved skills in order to 
help them to circumvent the negative impact of poor self-awareness in various aspects of their 
life. This could be particularly important if, as postulated by Bomilcar et al. (2018), further 
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examinations revealed that spared implicit metacognition is associated with better functional 
regulation in AD patients. 
However, the preservation of implicit metacognition does not appear to be universal in AD, as 
suggested by heterogeneity within the sample. Indeed, in the present experiment, only 45% of 
our patients (n = 9) presented impaired explicit metacognition (i.e., at chance metacognitive 
accuracy index) accompanied by preserved implicit metacognition (i.e., above chance 
metacognitive accuracy index). Among the remaining 55%, 25% (n = 5) presented both spared 
implicit and explicit processes – although the accuracy of their implicit judgments remained 
usually higher than the accuracy of their explicit judgments –, 15% (n = 3) presented an 
alteration of both types of metacognitive processes, and 15% (n = 3) demonstrated impaired 
implicit metacognition, but preserved explicit metacognition. These findings are, of course, to 
be further examined using procedure specifically designed to explore performance dissociation 
at the individual level. One factor that could account for this heterogeneity is the possible 
presence of visual agnosia in some of our AD patients. Indeed, our patients were not screened 
for visual agnosia before being included in the sample. Although the staircase procedure used 
here prevented individual differences at the cognitive level to influence the metacognitive 
performance, this hypothesis certainly deserved to be further investigated. However, in addition 
to provide preliminary evidence in favor of a possible double dissociation between explicit and 
implicit metacognitive monitoring processes, the pattern of results observed in this study is 
crucial because it indicates that the lack of self-awareness of some AD patients may result from 
an impairment of implicit metacognition rather than from an alteration of explicit metacognitive 
processes. Although there is still much to be done to understand the effect of such an implicit 
deficit on patients’ functioning, this line of research could prove crucial to understand self-
awareness deficits in AD. 
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In this context, future studies should be conducted to determine the nature of the variables that 
are involved in the apparition of a decrease in implicit metacognitive accuracy (i.e., in contrast 
to explicit metacognition, implicit metacognition was not found to be related to general 
cognitive functioning). Future research could also be conducted to determine whether a good 
implicit behavioral regulation always comes with a good implicit affective regulation, as 
postulated by the CAM model, or if a dissociation can be found between these two processes. 
Furthermore, in a clinical perspective, experiments should also be carried out to explore the 
functional impact of impaired implicit metacognition. For instance, studies should be conducted 
to examine whether patients with preserved implicit metacognition better manage their 
functional difficulties or show lower exposure to risky behaviors than patients with reduced 
implicit metacognitive skills. Such findings would contribute to improve our understanding of 
the heterogeneity of anosognosia in AD and would provide new leads to help us dealing with 
the many issues raised by unawareness in patients’ daily life. 
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Table 1. 
Demographic Data and Cognitive Performance for AD patients and their matched controls. 
 Healthy Controls AD 
Age (years) 73.5 (5.1) 74.6 (5.8) 
Education (Years) 12.2 (4.1) 13.0 (3.6) 
Sex (male : female) 13:7 13:7 
MMSE 29.3 (0.8) 21.2 (4.3)* 
Hit rate for perceptual task 0.67 (0.13) 0.68 (0.12) 
Note. AD = Alzheimer Disease; MMSE = Mini Mental State Examination; Hit rate = rate of 
correct identification for the perceptual identification task. * Significant differences between 
groups with a p <.001  
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Figure Captions 
Figure 1. Description of the experimental procedure. 
Figure 2. Metacognitive accuracy for the implicit (cue) and explicit (RCJ) measure of 
metacognitive monitoring in both AD patients and their matched controls; RCJ = Retrospective 
Confidence Judgment. 
 
